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Abstract
High altitude acclimatization and adaptation mechanisms have been well clarified, however, high altitude de-adaptation
mechanism remains unclear. In this study, we conducted a controlled study on cardiac functions in 96 healthy young male
who rapidly entered the high altitude (3700 m) and returned to the plains (1500 m) after 50 days. Ninety eight healthy male
who remained at low altitude were recruited as control group. The mean pulmonary arterial pressure (mPAP), left ventricular
ejection fraction (LVEF), left ventricular fraction shortening (LVFS), cardiac function index (Tei index) were tested. Levels of
serum creatine kinase isoform MB (CK-MB), lactate dehydrogenase isoenzyme-1 (LDH-1), endothelin-1 (ET-1), nitrogen oxide
(NO), serum hypoxia-inducible factor-1a (HIF-1a), 8-iso-prostaglandin F2a (8-iso PGF2a), superoxide dismutase (SOD) and
malonaldehyde (MDA) were measured at an altitude of 3700 m and 1500 m respectively. The results showed that after
short-term exposure to high altitude mPAP and Tei index increased significantly, while LVEF and LVFS decreased
significantly. These changes were positively correlated with altitude. On the 15
th day after the subjects returned to low
altitude, mPAP, LVEF and LVFS levels returned to the same level as those of the control subjects, but the Tei index in the
returned subjects was still significantly higher than that in the control subjects (P,0.01). We also found that changes in Tei
index was positively correlated with mPAP, ET-1, HIF-1a and 8-iso PGF2a levels, and negatively correlated with the level of
NO, LVEF, LVFS, CK-MB and LDH-1. These findings suggest that cardiac function de-adapts when returning to the plains after
short-term exposure to high altitude and the function recovery takes a relatively long time.
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Introduction
High altitude deadaptation, also called ‘‘oxygen intoxication
syndrome’’ or low altitude reaction, refers to the idiopathy involving
a series of changes in functional and metabolism or even structural
changes in high altitude natives or acclimatized high altitude residents
whentheydescendtotheplains.Recentstudieshaveshownthatwhen
descendingtotheplains,about50%–80%ofhighaltituderesidents or
natives present a series of clinical symptoms including dizziness,
palpitation, hypersomnia, malaise, chest tightening, precordial ache,
arrhythmia, hypophrenia; some show abnormal readings on
physiological parameters for heart, lung and blood, which continues
to drop even after reaching normal plain level, i.e., overcompensated;
a few individuals still present symptoms including hypoproteinemia,
oligocardia, decreased cardiac function and pulmonary hypertension
after twoyearsofcontinuousstay inthe plains; insomecases, thismay
last for a few years, and in the most severe cases the individuals were
forcedtoreturntohighaltitude.Werefertoalltheabovepathological
features as symptoms of ‘‘high altitude deadaptation reaction’’ or
‘‘high altitude deadaptation syndrome’’ [1–2]. Higher altitude, longer
stay at high altitude and older age at return to the plains all lead to
higherincidenceofthedisease.Itisgenerallybelievedthatexposureto
high altitude affects cardiac function to different degrees, which
increases as altitude and work intensity at high altitude increases;
when individuals leave high altitude environment, these influences on
heart soon disappear and the enlarged heart would quickly recover to
normal. However, a recent study by our group showed that the
cardiac structure of high altitude railway construction workers did not
yet fully recover five years after the workers left the high altitude
environment [3]. To further understand cardiac deadaptation on
return to the plains after short-term exposure to high altitude, we
focusedonchangesinpulmonaryarterypressureandcardiacfunction
on return to the plains after a 50-day exposure to high altitude, and
aimed to establish characteristics of cardiac deadaptation for high
altitude deadaptation syndrome.
Results
Changes in seroenzyme levels at different times after
return to the plains from short-term exposure to high
altitude
The serum creatine kinase isoform MB (CK-MB) concentration
of test subjects after short-term exposure to high altitude was
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31097significantly higher than that of the control subjects. The mean
CK-MB concentrations of the control group, test group,
moderate-severe AHAR (acute high altitude reaction, also known
as acute mild mountain sickness) subgroup, mild-moderate AHAR
subgroup and no AHAR subgroup were shown in Table 1. The
differences between the three test subgroups and the differences
between each test subgroup and the control group were all
significant (P,0.01). The differences between the CK-MB
concentration of the test group at 3700 m and that on the 2
nd,
15
th day of return to low altitude, and the difference between the
CK-MB concentration of the test group on the 2
nd day of return to
low altitude were significant (P,0.01); the CK-MB concentration
of the test group on the 15
th day of return to low altitude was not
significantly different from that of the control group (P.0.05,
Table 1 and Figure 1–2).
The serum lactate dehydrogenase isoenzyme-1 (LDH-1)
concentration of test subjects after short-term exposure to high
altitude was significantly higher than that of the control subjects.
The mean LDH-1 concentration of the control group, test group,
moderate-severe AHAR subgroup, mild-moderate AHAR sub-
group and no AHAR subgroup were shown in Table 1. The
differences between the three test subgroups and the differences
between each test subgroup and the control group were all
significant (P,0.01). The differences between the LDH-1
concentration of the test group at 3700 m and that on the 2
nd,
15
th day of return to low altitude, and the difference between the
LDH-1 concentration of the test group on the 2
nd and that on the
15
th day of return to low altitude were all significant (P,0.01); the
LDH-1 concentration of the test group on the 15
th day of return to
low altitude was not significantly different from that of the control
group (P.0.05, Table 1 and Figure 1–2).
Changes in serum cytokine levels at different times after
return to the plains from short-term exposure to high
altitude
The serum endothelin-1 (ET-1) concentration of test subjects
after short-term exposure to high altitude was significantly higher
than that of the control subjects. The mean ET-1 concentration of
the control group, test group, moderate-severe AHAR subgroup,
mild-moderate AHAR subgroup and no AHAR subgroup were
shown in Table 2. The differences between the three test
subgroups and the differences between each test subgroup and
the control group were all significant (P,0.01). The differences
between the ET-1 concentration of the test group at 3700 m and
that on the 2
nd,1 5
th day of return to low altitude, and the
difference between the ET-1 concentration of the test group on the
2
nd and that on the 15
th day of return to low altitude were all
significant (P,0.01); the ET-1 concentration of the test group on
the 15
th day of return to low altitude was not significantly different
from that of the control group (P.0.05,Table 2 and Figure 3–4).
The serum nitrogen oxide (NO) concentration of test subjects
after short-term exposure to high altitude was significantly lower
than that of the control subjects. The mean NO concentration of
the control group, test group, moderate-severe AHAR subgroup,
mild-moderate AHAR subgroup and no AHAR subgroup were
shown in Table 2. The differences between the three test
Figure 1. Comparison of serum myocardial enzyme and
oxygen free radical levels between individuals with different
degrees of high altitude reaction. (Note: P,0.01, P,0.05,
compared with control group;
DP,0.01 compared with unresponsive to
AHAR group,
# P,0.01 compared with mild and moderate AHAR
group.)
doi:10.1371/journal.pone.0031097.g001
Figure 2. Comparison of serum myocardial enzyme and
oxygen free radical levels between individuals with different
times of return to the plains from high altitude. (Note: P,0.01,
P,0.05, compared with control group;
DP,0.01 compared with
altitude exposure group,
# P,0.01 compared with returned 2days
group.)
doi:10.1371/journal.pone.0031097.g002
Table 1. Test results of seroenzyme levels at different times after return to plain from short-term exposure to high altitude (U/L).
Group Cases 50
th day of high altitude exposure 2
nd day after return to plain 15
th day after return to plain
CK-MB LDH-1 CK-MB LDH-1 CK-MB LDH-1
Observation group 96 47.29610.41 138.60627.90 25.3166.46 84.47613.28 12.7662.12 56.1668.31
Control group 98 12.2461.97 55.6064.89 12.3661.27 55.7564.83 12.7961.35 55.7364.85
P value P,0.01 P,0.01 P,0.01 P,0.01 P.0.05 P.0.05
doi:10.1371/journal.pone.0031097.t001
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control group were all significant (P,0.01). The differences
between the NO concentration of the test group at 3700 m and
that on the 2
nd,1 5
th day of return to low altitude, and the
difference between the NO concentration of the test group on the
2
nd and that on the 15
th day of return to low altitude were all
significant (P,0.01); the NO concentration of the test group on
the 15
th day of return was not significantly different from that of
the control group (P.0.05, Table 2 and Figure 3–4).
The serum hypoxia-inducible factor-1a (HIF-1a) concentration
of test subjects after short-term exposure to high altitude was
significantly lower than that of the control subjects. The mean
HIF-1a concentration of the control group, test group, moderate-
severe AHAR subgroup, mild-moderate AHAR subgroup and no
AHAR subgroup were shown in Table 3. The differences between
the three test subgroups and the differences between each test
subgroup and the control group were all significant (P,0.01). The
differences between the HIF-1a concentration of the test group at
3700 m and that on the 2
nd,1 5
th day of return to low altitude, and
the difference between the HIF-1a concentration of the test group
on the 2
nd and that on the 15
th day of return to low altitude were
all significant (P,0.01); the HIF-1a concentration of the test group
on the 15
th day of return to low altitude was not significantly
different from that of the control group (P.0.05, Table 3 and
Figure 3–4).
The serum 8-iso-prostaglandin F2a (8-iso-PGF2a) concentration
of test subjects after short-term exposure to high altitude was
significantly lower than that of the control subjects. The mean 8-
iso-PGF2a concentration of the control group, test group,
moderate-severe AHAR subgroup, mild-moderate AHAR sub-
group and no AHAR subgroup were shown in Table 3. The
differences between the three test subgroups and the differences
between each test subgroup and the control group were all
significant (P,0.01). The differences between the 8-iso-PGF2a
concentration of the test group at 3700 m and that on the 2
nd,1 5
th
day of return to low altitude, and the difference between the 8-iso-
PGF2a concentration of the test group on the 2
nd and that on the
15
th day of return to low altitude were all significant (P,0.01); the
8-iso-PGF2a concentration of the test group on the 15
th day of
return to low altitude was not significantly different from that of
the control group (P.0.05. Table 3 and Figure 3–4).
Changes in blood oxygen free radical levels at different
times after return to the plains from short-term exposure
to high altitude
The serum superoxide dismutase (SOD) concentration of test
subjects after short-term exposure to high altitude was significantly
lower than that of the control subjects. The mean SOD
concentration of the control group, test group, moderate-severe
AHAR subgroup, mild-moderate AHAR subgroup and no AHAR
subgroup were shown in Table 4. The differences between the
three test subgroups and the differences between each test
subgroup and the control group were all significant (P,0.01).
Figure 3. Comparison of plasma cytokine levels between
individuals with different degrees of high altitude reaction.
(Note: P,0.01, P,0.05, compared with control group;
DP,0.01
compared with unresponsive to AHAR group,
# P,0.01 compared with
mild and moderate AHAR group.)
doi:10.1371/journal.pone.0031097.g003
Figure 4. Comparison of plasma cytokine levels between
individuals with different times of return to the plains from
high altitude. (Note: P,0.01, P,0.05, compared with control
group;
DP,0.01 compared with altitude exposure group,
# P,0.01
compared with returned 2days group.)
doi:10.1371/journal.pone.0031097.g004
Table 2. Test results of serum diastolic and systolic factor levels and pulmonary artery pressure at different times after return to
plain from short-term exposure to high altitude.
Group Cases 50
th day of high altitude exposure 2
nd day after return to plain 15
th day after return to plain
ET-1 (ng/L) NO (mmol/L)
mPAP
(mmHg) ET-1 (ng/L) NO (mmol/L)
mPAP
(mmHg) ET-1 (ng/L) NO (mmol/L)
mPAP
(mmHg)
Observation group 96 56.6968.51 66.0467.91 29.0864.22 44.2568.51 74.5166.55 23.0563.18 33.4663.68 81.5063.61 18.9661.75
Control group 98 33.2762.86 82.5964.02 18.5061.31 34.0461.88 82.8163.36 18.2961.07 32.8861.69 83.7662.04 18.1160.94
P value P,0.01 P,0.01 P,0.01 P,0.01 P,0.01 P,0.01 P.0.05 P.0.05 P.0.05
doi:10.1371/journal.pone.0031097.t002
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at 3700 m and that on the 2
nd,1 5
th day of return to low altitude,
and the difference between the SOD concentration of the test
group on the 2
nd and that on the 15
th day of return to low altitude
were all significant (P,0.01); the SOD concentration of the test
group on the 15
th day of return to low altitude was not significantly
different from that of the control group (P.0.05, Table 4 and
Figure 1–2).
The serum malonaldehyde (MDA) concentration of test subjects
after short-term exposure to high altitude was significantly higher
than that of the control subjects. The mean MDA concentration of
the control group, test group, moderate-severe AHAR subgroup,
mild-moderate AHAR subgroup and no AHAR subgroup were
shown in Table 4. The differences between the three test
subgroups and the differences between each test subgroup and
the control group were all significant (P,0.01). The differences
between the MDA concentration of the test group at 3700 m and
that on the 2
nd,1 5
th day of return to low altitude, and the
difference between the MDA concentration of the test group on
the 2
nd and that on the 15
th day of return to low altitude were all
significant (P,0.01); the MDA concentration of the test group on
the 15
th day of return to low altitude was not significantly different
from that of the control group (P.0.05, Table 4 and Figure 1–2).
Changes in cardiac function at different times after return
to the plains from short-term exposure to high altitude
The cardiac function index (Tei index) of test subjects after
short-term exposure to high altitude was significantly higher than
that of the control subjects. The mean Tei index for the left and
right ventricle of the control group, test group, moderate-severe
AHAR subgroup, mild-moderate AHAR subgroup and no AHAR
subgroup were shown in Table 5. The differences between the
three test subgroups and the differences between each test
subgroup and the control group were all significant (P,0.01).
The differences between the Tei index of the test group at 3700 m
and that on the 2
nd,1 5
th day of return to low altitude, and the
difference between the Tei index of the test group on the 2
nd and
that on the 15
th day of return to low altitude were all significant
(P,0.01); the Tei index of the test group on the 15
th day of return
to low altitude was still significantly different from that of the
control group (P,0.05, see Table 5, Table 6 and Figure 5–6).
The left ventricular ejection fraction (LVEF) of test subjects after
short-term exposure to high altitude was significantly lower than
that of the control subjects. The mean LVEF and RVEF of the
control group, test group, moderate-severe AHAR subgroup mild-
moderate AHAR subgroup and no AHAR subgroup were
summarized in Table 5 and 6. The differences between the three
test subgroups and the differences between each test subgroup and
the control group were all significant (P,0.01). The differences
between the LVEF of the test group at 3700 m and that on the
2
nd,1 5
th day of return to low altitude, and the difference between
the LVEF of the test group on the 2
nd and that on the 15
th day of
return to low altitude were all significant (P,0.01); the LVEF of
the test group on the 15
th day of return to low altitude was not
significantly different from that of the control group (P.0.05,
Table 5, Table 6 and Figure 5–6).
The left ventricular fraction shortening (LVFS) of test subjects
after short-term exposure to high altitude was significantly lower
than that of the control subjects. The mean LVFS and RVFS of
the control group, test group, moderate-severe AHAR subgroup,
mild-moderate AHAR subgroup and no AHAR subgroup were
summarized in Table 5 and 6. The differences between the three
test subgroups and the differences between each test subgroup and
the control group were all significant (P,0.01). The differences
between the LVFS of the test group at 3700 m and that on the 2
nd,
15
th day of return to low altitude, and the difference between the
LVFS of the test group on the 2
nd and that on the 15
th day of
return to low altitude were all significant (P,0.01); the LVFS of
the test group on the 15
th day of return to low altitude was not
significantly different from that of the control group (P.0.05,
Table 5, Table 6 and Figure 5–6).
The mean pulmonary arterial pressure (mPAP) of test subjects
after short-term exposure to high altitude was significantly higher
than that of the control subjects. The mean mPAP of the control
Table 3. Test results of serum cytokine HIF-1             levels at different times after return to plain from short-term
exposure to high altitude.
Group Cases 50
th day of high altitude exposure 2
nd day after return to plain 15
th day after return to plain
HIF-1a (pg/L) 8-iso-PGF2a (mg/L) HIF-1a (pg/L) 8-iso-PGF2a (mg/L) HIF-1a (pg/L) 8-iso-PGF2a (mg/L)
Observation group 96 91.16620.58 8.3361.02 70.9968.22 6.5461.01 52.3164.92 5.1660.47
Control group 50 50.5763.27 5.0760.32 52.5862.34 5.1160.28 53.6561.86 5.3060.21
P value P,0.01 P,0.01 P,0.01 P,0.01 P.0.05 P.0.05
doi:10.1371/journal.pone.0031097.t003
Table 4. Test results of serum oxygen free radical SOD and MDA levels at different times after return to plain from short-term
exposure to high altitude.
Group Cases 50
th day of high altitude exposure 2
nd day after return to plain 15
th day after return to plain
SOD (nu/mL) MDA (mmol/L) SOD (nu/mL) MDA (mmol/L) SOD (nu/mL) MDA (mmol/L)
Observation group 96 62.1567.80 7.4960.97 72.1068.66 6.4760.75 79.8263.15 5.5160.42
Control group 98 81.0363.53 5.4960.34 81.6462.41 5.4460.22 81.5762.99 5.4860.24
P value P,0.01 P,0.01 P,0.01 P,0.01 P.0.05 P.0.05
doi:10.1371/journal.pone.0031097.t004
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 group, test group, moderate-severe AHAR subgroup, mild-
moderate AHAR subgroup and no AHAR subgroup were
summarized in Table 2. The differences between the three test
subgroups and the differences between each test subgroup and the
control group were all significant (P,0.01). On the 2nd and that
on the 15th day after return to the plains (1500 m), the mean
mPAPs of the test group were 23.0563.18 mmHg and
18.9661.75 mmHg, respectively. The differences between the
mPAP of the test group at 3700 m and that on the 2
nd,1 5
th day of
return to low altitude, and the difference between the mPAP of the
test group on the 2
nd and that on the 15
th day of return to low
altitude were all significant (P,0.01); the mPAP of the test group
on the 15
th day of return to low altitude was not significantly
different from that of the control group (P.0.05, Table 2 and
Figure 5–6).
Discussion
There has been no previous report on the cardiac deadaptation
during the high altitude deadaptation process and, there has no
been study on the cardiac function deadaptation at return to the
plains after short-term high altitude exposure. Heath et al.
proposed that as high altitude residents descended to the plains,
the abnormal environmental stimulation was removed and these
people were no longer subject to health threat [4–6]. However,
Vogel reported that when high altitude natives (43,50 years old)
entered sea level, the stroke index (SI) of their hearts significantly
increased, heart rate significantly decreased, whereas the cardiac
index (CI) remained unchanged [7–9]. Tei index is a new index
evaluating global cardiac function using ultrasonic cardiogram,
a.k.a. ventricular myocardial performance index (VMPI), first
proposed by Japanese scholar Tei et al. [9] and adopted in clinical
application. Tei index is a ratio of the sum of ventricular
isovolumic contraction (ICT) and, isovolumic relaxation (IRT) and
the ventricular ejection time (ET). The index reflects the global
cardiac systolic and diastolic function. Both ICT extending, ET
shortening during systolic dysfunction and extending IRT, ET
shortening during diastolic dysfunction can cause an increase in
Tei index. As Tei index evaluates the global cardiac function of the
left ventricle, and is easy to measure and repeat, not influenced by
factors including age, heart rate, geometric shape of the ventricle,
ventricle systolic and diastolic pressures, it is a more scientific way
to measure cardiac function than evaluating the systolic and
diastolic functions of the heart alone [10], The ventricular ejection
fraction (EF) reflects only the ventricular systolic function under
the normal EF circumstances, while Tei index reflects the degree
of ventricular diastolic dysfunction. It is more accurate to use left
ventricular diastolic function as a sensitive indicator [11], which
has been widely used in clinical applications. In recent years some
have also calculated Tei index from right ventricular isovolumic
contraction time, right ventricular isovolumic relaxation time and
right ventricle ejection time to evaluate the systolic and diastolic
functions of the right ventricle [12–13]. In this study, we found
that rapid exposure to high altitude of the plains residents could
lead to an increase in pulmonary artery pressure and a decrease in
left ventricle function, even is the high altitude exposure was only
short term; these changes were positively correlated with altitude
and degree of altitude stress, i.e. higher altitude and worse altitude
reaction led to more severely impaired left ventricle function. We
also found the LVEF and LVFS decreased significantly. On the
15
th day after return to low altitude, the test subjects’ LVEF and
LVFS had recovered to the level of control subjects; however, the
Tei index of the left and right ventricle had not, indicating a low
global cardiac function at that time point. Our results suggest that
cardiac deadaptation process exists in population returning to the
plains after short-term exposure to high altitude; in particular, the
recovery of the left and right ventricle function is slow and it may
still be in the deadaptation condition 15 days after return to low
altitude, which needs to be attended to clinically.
Many factors may influence the systolic and diastolic function of
the right ventricle, and the pulmonary artery pressure is the most
important one. It is well known that alveolar hypoxia is a direct
trigger of pulmonary vessel contraction.In this study, we found
that exposure to high altitude could quickly increase the vascular
contracting factors and decrease the vascular relaxing factors in
the plasma, after subjects return to the plains from high altitude,
Table 5. Test results of right cardiac function at different times after return to plain from short-term exposure to high altitude.
Group Cases 50
th day of high altitude exposure 2
nd day after return to plain 15
th day after return to plain
Tei Index RVEF (%) RVFS (%) Tei Index RVEF (%) RVFS (%) Tei Index RVEF (%) RVFS (%)
Observation
group
96 0.5660.16 45.7365.85 25.2463.23 0.4960.16 46.6765.77 27.7663.84 0.4760.16 61.3564.75 34.5763.29
Control group 98 0.3360.03 56.8563.78 33.7363.58 0.3260.02 56.9563.38 34.2363.18 0.3460.03 57.2763.35 34.8963.27
P value P,0.01 P,0.01 P,0.01 P,0.01 P,0.01 P,0.01 P,0.01 P.0.05 P.0.05
doi:10.1371/journal.pone.0031097.t005
Table 6. Test results of left cardiac function at different times after return to plain from short-term exposure to high altitude.
Group Cases 50
th day of high altitude exposure 2
nd day after return to plain 15
th day after return to plain
Tei Index LVEF (%) LVFS (%) Tei Index LVEF (%) LVFS (%) Tei Index LVEF (%) LVFS (%)
Observation
group
96 0.4960.09 48.7166.81 27.4263.93 0.4060.08 55.8766.07 32.7663.14 0.4060.08 63.5064.45 36.2762.19
Control group 98 0.3160.03 64.8364.37 36.6962.39 0.3260.02 64.4463.53 36.5962.25 0.3260.02 64.3663.09 36.4261.91
P value P,0.01 P,0.01 P,0.01 P,0.01 P,0.01 P,0.05 P,0.05 P.0.05 P.0.05
doi:10.1371/journal.pone.0031097.t006
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vascular diastolic factor NO release gradually increases, both
recover to normal level as the in the control subjects 15 days after
the return to low altitude. ET-1 is the most potent internal
vascular contracting factor currently known and lungs are the most
important organ for the function and metabolism of ET-1 [14].
Under hypoxia the endothelial cells in the lung tissue are damaged
and ET-1 gene expression is up-regulated; as the serum ET-1
concentration increases, ET-1 combines ETAR on the pulmonary
vascular smooth muscles and causes opening of Ca
2+ channels and
increase in intracellular Ca
2+ concentration, which leads to
contraction of pulmonary vessels and increase in pulmonary
artery pressure [15]. Selective ET-1-A antagonist can inhibit
hypoxic pulmonary vessel contraction, inhibit or decrease
pulmonary hypertension under hypoxia [16], through which
hypoxia can regulate ET-1 gene expression via inducing HIF-1a
and ET-1 levels were linearly correlated with pulmonary artery
pressure. After the subjects returned to low altitude, HIF-1a and
ET-1 release gradually decreased, and recovered to normal
control levels in 15 days after return to low altitude. HIF -1a is
an important protein regulatory factor produced by the body
under hypoxia, which can regulates many target genes [17–18],
including ET-1 and NO. Our study found that HIF -1a level is
positively correlated with mPAP significantly. Therefore, changes
in HIF-1a level caused by hypoxia may play an important role in
the pathogenesis of hypoxic pulmonary hypertension [19]. 8-iso-
PGF2a is a recently discovered biologically active prostaglandin-
like substance. Romero et al. [20] found that 8-iso-PGF2a had
strong effect in vessel contraction and antinatriuresis; it was
involved in generation of high blood pressure even when Ang II
level was normal. In addition, the 8-iso-PGF2a concentration in
the body fluid is very stable, hence it has been considered the most
ideal biochemical index for evaluating free radical oxidation
intensity in living bodies [21–22]. Our study found that 8-iso-
PGF2a level is positively correlated with mPAP significantly.
Therefore hypoxia induced serum 8-iso- PGF2a level increase also
plays an important role in the generation of hypoxic pulmonary
hypertension. Increase in pulmonary artery pressure adds to the
load on right ventricle; decrease in pulmonary artery pressure
alleviates the pressure load on right ventricle and facilitates the
recovery of right ventricle. Therefore, 8-iso-PGF2a level on right
ventricular function has a direct influence.
Our results showed that exposure to high altitude led to
myocardial damage; the myocardial enzyme activities increased.
Upon return to the plains from high altitude, myocardial enzyme
CK-MB and LDH-1 activities dropped quickly, and returned to
normal control level in 15 days. Upon return to the plains from
high altitude, LVEF and LVFS increased quickly, and recovered
to normal control level in 15 days after return to low altitude.
However, on the 15
th day after return, the Tei index that indicates
cardiac function still remained high. In particular, acute hypoxia
could cause cardiomyocyte membrane damage, leading to
decrease in membrane fluidity and increase in membrane
permeability [23], which led to outflow of CK-MB and LDH-1
and further aggravated myocardial damages. In addition, hypoxia
could also lead to increase in generation of oxygen free radicals,
which could further impair cardiac muscles. It is known that
oxygen free radicals can lead to oxidation of unsaturated fatty acid
in the cell membrane, inactivation of intracellular enzymes and
cell membrane rupture, causing severe damages to tissues and cells
[24]. Our study also found that exposure to high altitude could
lead to increase in serum MDA level and decrease in SOD level;
the magnitude of the changes paralleled the degree of high altitude
reaction: more severe high altitude reaction led to more increase of
MDA level. When subjects returned to low altitude, the MDA
activity decreased and SOD level increased, both having
recovered to normal control level on the 15
th days after the
return to low altitude. It is thus evident that after return to the
plains, the oxidative damage is alleviated and the antioxidative
ability is increased, which leads to more removal of oxygen free
radicals in the organism and restored oxidation-antioxidation
balance.
In conclusion, hypoxia at high altitude can lead to increase in
pulmonary artery pressure and decrease in global cardiac function
at rapid exposure high altitude, which involves disturbed balance
of plasma systolic and diastolic factor release and damage to the
cardiac muscles. Damages to the cardiac structure and function
caused by short-term rapid exposure to high altitude are
reversible. When individuals return to the plains, the myocardial
damages can quickly recover and the cardiac function quickly
restores to normal control level in about half a month; however,
full recovery of global ventricle function takes longer time. During
Figure 5. Comparison of cardiac function and pulmonary
artery pressure between individuals with different degrees of
high altitude reaction. (Note: P,0.01, P,0.05, compared with
control group;
DP,0.01 compared with unresponsive to AHAR group,
# P,0.01 compared with mild and moderate AHAR group.)
doi:10.1371/journal.pone.0031097.g005
Figure 6. Comparison of cardiac function and pulmonary
artery pressure between individuals with different times of
return to the plains from high altitude. (Note: P,0.01, P,0.05,
compared with control group;
DP,0.01 compared with altitude
exposure group,
# P,0.01 compared with returned 2days group.)
doi:10.1371/journal.pone.0031097.g006
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overtiredness and infection, in order to prevent aggravating
myocardial damages which may cause high altitude deadaptation
syndrome [25].
Materials and Methods
Subjects
Ninety six young males who quickly entered high altitude area
(3700 m) from low altitude area (1500 m) and were engaged in
heavy labor after ‘‘4.14’’ Yushu earthquake in Qinghai province
were selected using random number table. All subjects gave their
informed consent in writing. All test subjects were male, aging 18–
35 years old with a mean of 21.863.6 years old. All subjects were
immediately engaged in heavy labors including rescue work,
loading and unloading goods and materials, clearing seismic ruins
for 8,10 hours per day. On the 50
th day completing their heavy
labor duty at high altitude, the 2
nd and 15
th day after a 48-hour by
bus return to proper station (1500 m) respectively, the subjects’
mean pulmonary arterial pressure (mPAP), left ventricular ejection
fraction (LVEF), left ventricular fraction shortening (LVFS),
cardiac function index (Tei index), levels of serum creatine kinase
isoform MB (CK-MB), lactate dehydrogenase isoenzyme-1 (LDH-
1), endothelin-1 (ET-1), nitrogen oxide (NO), serum hypoxia-
inducible factor-1a (HIF-1a), 8-iso-prostaglandin F2a (8-iso
PGF2a), superoxide dismutase (SOD) and malonaldehyde (MDA)
were measured. Ninety eight young males from the same unit and
not exposed to high altitude were used as control subjects. The age
of the control subject ranged from 19 to 32 years old with a mean
of 22.963.5 years old. This study was approved by the medical
ethical committee of the Third Military Medical University.
Acute high altitude reaction (AHAR) symptom scale
assessment and scale division
On each day of the subjects’ 50-day stay at high altitude, a
medical doctor was responsible for examining and recording their
AHAR symptoms, which were scaled and divided into groups
according to Chinese AHAR semiotic assessment method: a total
score of 1,4 was normal, 5,10 mild AHAR, 11,15 moderate
AHAR and above 16 severe AHAR [26]. Based on the scale
results, 71 out of 96 (74.0%) test subjects showed AHAR, including
24 cases of severe AHAR (group A) and 47 cases of moderate
AHAR (group B). There were 25 (26.0%) test subjects who did not
show AHAR.
Measurement of serum ET-1 and NO
Fasting venous blood (4 ml) was collected to anticoagulant tube
containing 0.2 ml 0.2% EDTA, centrifuged at 3000 r/min 4uC
(centrifugal radius 15 cm) for 10 min to separate plasma, and
stored in 230uC refrigerator for testing. Radioimmunoassay
method was applied to measure ET-1 level (kit provided by Beijing
Dongya Immunology Research Institute); nitric acid reduction
method was applied to measure NO level (kit purchased from
Shenzhen Jingmei Bioengineering Inc.). All operations were
performed according to instructions in the kits.
Measurement of 8-iso PGF2a, SOD and MDA
Fasting venous blood (5 ml) was collected (with EDTA),
centrifuged at 3000 r/min for 10 min at 4uC to separate plasma,
and stored in 280uC previous testing. Enzyme liked immunosor-
bent assay (ELISA) was used to measure 8-iso PGF2a concentra-
tion (kit purchased from ADL company, USA); operation was
performed strictly according to kit instruction; optical density at
450 nm was determined with ELISA reader (Bio-Rad 3550).
Chemical colorimetric analysis was performed to measure SOD
and MDA levels (kit produced by Nanjing Jiancheng Bioengi-
neering Research Institute).
Measurement of serum HIF-1a level
Double antibody sandwich ELISA (DAS-ELISA) was used (kit
purchased from Beijing Zhongshan Jinqiao Bioengineering Inc.);
operation was performed strictly according to kit instruction;
optical density at 450 nm was determined with ELISA reader
(Bio-Rad 3550); standard curve was plotted and serum HIF-1a,
VEGF level calculated.
Measurement of myocardial enzymes
Morning fasting venous blood (3 ml) was collected (with
EDTA), centrifuged at 3500 r/min for 10 min at 4uC to separate
plasma, and stored in 280uC before testing. Performance rate
method was applied to measure CK-MB and LDH-1 concentra-
tions (kit purchased from Lanzhou Beiken Biology Inc.); operation
was performed strictly according to kit instruction; fully automated
biochemistry analyzer (BS-400) was used for reading.
Measurement of mPAP
Color Doppler echocardiography instrument (Kangbo RT
6800) was used to measure the right ventricular pre-ejection
period (RVPEP) and pulmonary artery acceleration time (AT)
from pulmonary artery blood flow spectra; RVPEP refers to the
time interval between the onset of Q wave in ECG and the onset
of pulmonary artery systolic blood flow spectra, whereas AT refers
to the time interval between the onset and the peak of pulmonary
artery systolic blood flow spectra. mPAP (mmHg)=42.1(RVPEP/
AT)215.7 [27].
Measurement of cardiac function
Color Doppler ultrasound system (GE LOGIQ-3) was used to
measure Tei index, LVEF and LVFS. The subjects took left lateral
position after 1-hour rest, and the apical four-chamber and five-
chamber views were obtained. (1) Pulsed Doppler sample volume
was placed at mitral valve and aortic valve to record blood flow
spectra when heart rate was in steady-state; the time interval
between the end of mitral valve blood flow A peak and the
beginning of the E peak in the next cardiac cycle (line a) and the
aortic ejection time (line b) were measured. Tei index was
calculated with formula Tei Index=(a2b/b) [9]. (2) Simpson’s
method was applied to calculate the subjects’ LVEF and LVFS
[28–29]. Right ventricular systolic and diastolic function were
evaluated by measuring the spectrum of tricuspid annular wall
motion according to the literature [30–31].
Statistical analysis
SPSS software was used for statistical analysis. Data were
presented as mean 6 standard deviation (x6SD); one-way
ANOVA was used for intergroup comparison; differences with
P,0.05 were considered statistically significant.
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